Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.49 is in line with its 5-year average of 3.80, near the low end of its 5-year range (2.95–6.16).
As of the fiscal period ended Tuesday, June 30, 2026. 3.38% above its 12-month average of 3.38.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.49.
QUICK RATIO (ACID-TEST)
3.49
QUICK RATIO (ACID-TEST) AVG TTM
3.38
QUICK RATIO (ACID-TEST) AVG 3Y
3.54
QUICK RATIO (ACID-TEST) AVG 5Y
3.80
QUICK RATIO (ACID-TEST) AVG 10Y
6.02
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.38%
CURRENT VS 3Y AVG
-1.54%
CURRENT VS 5Y AVG
-8.09%
CURRENT VS 10Y AVG
-41.97%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+4.19%
vs the sector median at left
Kiniksa Pharmaceuticals International, plc
Market Cap
$5.88B
Quick Ratio (Acid-Test)
3.49
TTM Avg
3.38
3Y Avg
3.54
5Y Avg
3.80
Market Cap
$5.93B
Quick Ratio (Acid-Test)
30.96
TTM Avg
15.27
3Y Avg
11.45
5Y Avg
10.17
Market Cap
$5.81B
Quick Ratio (Acid-Test)
2.49
TTM Avg
5.72
3Y Avg
6.91
5Y Avg
11.65
Market Cap
$5.81B
Quick Ratio (Acid-Test)
3.82
TTM Avg
3.07
3Y Avg
3.52
5Y Avg
5.23
Market Cap
$5.59B
Quick Ratio (Acid-Test)
22.20
TTM Avg
29.94
3Y Avg
20.76
5Y Avg
18.56
Market Cap
$6.19B
Quick Ratio (Acid-Test)
3.20
TTM Avg
3.62
3Y Avg
5.38
5Y Avg
6.45
Market Cap
$5.48B
Quick Ratio (Acid-Test)
1.36
TTM Avg
1.16
3Y Avg
1.16
5Y Avg
1.16
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | $5.88B | 3.49 | 3.38 | 3.54 | 3.80 |
| GRAIL Inc. (GRAL)vs › | $5.86B | 10.74 | 11.09 | 6.26 | 5.77 |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.93B | 30.96 | 15.27 | 11.45 | 10.17 |
| Kodiak Sciences Inc. (KOD)vs › | $5.81B | 2.49 | 5.72 | 6.91 | 11.65 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.81B | 3.82 | 3.07 | 3.52 | 5.23 |
| CG Oncology Inc. (CGON)vs › | $5.59B | 22.20 | 29.94 | 20.76 | 18.56 |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.19B | 3.20 | 3.62 | 5.38 | 6.45 |
| RadNet, Inc. (RDNT)vs › | $5.51B | 1.48 | 1.94 | 1.50 | 1.26 |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.48B | 1.36 | 1.16 | 1.16 | 1.16 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.29B | 3.28 | 2.29 | 2.05 | 2.40 |
Quick Ratio
3.49
Excludes inventory
Current Ratio
3.90
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.49 |
| 2026-03-31 | 3.33 |
| 2025-12-31 | 3.39 |
| 2025-09-30 | 3.51 |
| 2025-06-30 | 3.16 |
| 2025-03-31 | 3.43 |
| 2024-12-31 | 3.04 |
| 2024-09-30 | 2.95 |
| 2024-06-30 | 3.16 |
| 2024-03-31 | 3.79 |
| 2023-12-31 | 3.85 |
| 2023-09-30 | 4.31 |
| 2023-06-30 | 4.68 |
| 2023-03-31 | 5.69 |
| 2022-12-31 | 4.71 |
| 2022-09-30 | 4.02 |
| 2022-06-30 | 3.67 |
| 2022-03-31 | 3.68 |
| 2021-12-31 | 4.30 |
| 2021-09-30 | 6.16 |
| 2021-06-30 | 6.15 |
| 2021-03-31 | 7.71 |
| 2020-12-31 | 10.46 |
| 2020-09-30 | 15.20 |
| 2020-06-30 | 12.87 |
| 2020-03-31 | 11.02 |
| 2019-12-31 | 8.68 |
| 2019-09-30 | 9.74 |
| 2019-06-30 | 9.82 |
| 2019-03-31 | 9.08 |
| 2018-12-31 | 7.37 |
| 2018-09-30 | 12.19 |
| 2018-06-30 | 15.72 |
| 2018-03-31 | 11.55 |
| 2017-12-31 | 2.70 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
